• Publications
  • Influence
Diagnosis, management, and treatment of hepatitis C: An update
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology.
  • 2,954
  • 187
  • PDF
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy.Expand
  • 1,912
  • 121
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, with estimates of 4 million HCV-infected individuals in the United States and 170 million worldwide.Expand
  • 2,020
  • 102
  • PDF
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means ofExpand
  • 1,106
  • 58
Multimodal population brain imaging in the UK Biobank prospective epidemiological study
Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problemExpand
  • 555
  • 56
  • PDF
Genetic epidemiology of hepatitis C virus throughout egypt.
Hepatitis C virus (HCV) infection is a major health problem in Egypt, where the seroprevalence is 10-20-fold higher than that in the United States. To characterize the HCV genotype distribution andExpand
  • 362
  • 43
  • PDF
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
The standard of care (SOC) therapy for patients with chronic hepatitis C virus (HCV) infection has been the use of both peginterferon (PegIFN) and ribavirin (RBV). These drugs are administered forExpand
  • 1,106
  • 37
  • PDF
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
CONTEXT Use of antiretroviral drugs, including protease inhibitors, for treatment of human immunodeficiency virus (HIV) infection has been anecdotally associated with hepatotoxicity, particularly inExpand
  • 948
  • 37
  • PDF
Occult hepatitis B.
Worldwide, chronic hepatitis B virus (HBV) infection is the primary cause of cirrhosis and hepatocellular carcinoma and is one of the ten leading causes of death. Traditionally, people with chronicExpand
  • 495
  • 35
Diagnosis, management, and treatment of hepatitis C
These recommendations provide a data-supported approach. They are based on the following: (1) a formal review and analysis of the recently published world literature on the topic (Medline search);Expand
  • 1,758
  • 34
  • PDF